Product Information
MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2170 per GM under NDC 45802011942. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802011942
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA076067On Market Since
7/18/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2170 per GM |
|---|---|
| All-time high | $0.3588 (Aug 16, 2023) |
| All-time low | $0.1552 (Jan 18, 2023) |
| 52-week high | $0.2544 |
| 52-week low | $0.2170 |
| Median price | $0.2200 |
| Average price | $0.2225 |
| Largest weekly change | +45.4% (Mar 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2170 per GM (NDC 45802011942), effective Jun 24, 2026.
How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 9.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.1552 (Jan 18, 2023) to a high of $0.3588 (Aug 16, 2023), with a median of $0.2200 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?
4 NADAC-published products share the same active ingredient, strength, and dosage form as MOMETASONE FUROATE 0.1% OINT, but none are currently priced below it.
Who manufactures MOMETASONE FUROATE 0.1% OINT?
MOMETASONE FUROATE 0.1% OINT (NDC 45802011942) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification